Work

Figure S1 & S2 from Inhibition of BCL2 Family Members Increases the Efficacy of Copper Chelation in BRAFV600E-Driven Melanoma

Year: 2023

Type: other

Abstract: Supplemental Figure S1. TTM reduces MAPK pathway activation without inducing apoptosis in BRAFV600E-positive melanoma cells. Supplemental Figure S2. MAPK inhibitors reduce BRAFV600E-positive melanoma cell viability without inducing apoptosis.

DOI: 10.1158/0008-5472.24895339

Authors: Ye-Jin Kim, Tiffany Tsang, Grace R. Anderson, Jessica M. Posimo, Donita C. Brady

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4390100984

Cites:

Cited by:

Related to: 10